Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations
International Journal of Neonatal Screening · 11.04.2023 · 9 (2) · 22
DOI: 10.3390/ijns9020022 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 11.04.2023. Verfasst von Jovanka R King und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy & Clinical Immunology, Women's and Children's Hospital Network, North Adelaide, SA 5006, Australia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inborn errors of immunity (IEI) are a group of over 450 genetically distinct conditions associated with significant morbidity and mortality, for which early diagnosis and treatment improve outcomes. Newborn screening for severe combined immunodeficiency (SCID) is currently underway in several countries, utilising a DNA-based technique to quantify T cell receptor excision circles (TREC) and kappa-deleting recombination excision circles (KREC). This strategy will only identify those infants with an IEI associated with T and/or B cell lymphopenia. Other severe forms of IEI will not be detected. Up-front, first-tier genomic-based newborn screening has been proposed as a potential approach by which to concurrently screen infants for hundreds of monogenic diseases at birth. Given the clinical, phenotypic and genetic heterogeneity of IEI, a next-generation sequencing-based newborn screening approach would be suitable. There are, however, several ethical, legal and social issues which must be evaluated in detail prior to adopting a genomic-based newborn screening approach, and these are discussed herein in the context of IEI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Allergy & Clinical Immunology, Women's and Children's Hospital Network, North Adelaide, SA 5006, Australia.
- Immunology Directorate, SA Pathology, Adelaide, SA 5000, Australia.
- Robinson Research Institute and Discipline of Paediatrics, School of Medicine, University of Adelaide, North Adelaide, SA 5006, Australia.
- Department of Historical, Philosophical and Religious Studies, Umeå University, SE-90187 Umeå, Sweden.
- Department of Biosciences and Nutrition, Neo, Karolinska Institutet, SE-14183 Huddinge, Sweden.
ORCID-Profile: Jovanka R King
Zitieren
APA
King, J. R., Grill, K., & Hammarström, L. (2023). Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations. International Journal of Neonatal Screening, 9(2), 22. https://doi.org/10.3390/ijns9020022
Vancouver
King JR, Grill K, Hammarström L. Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations. International Journal of Neonatal Screening. 2023;9(2):22. doi:10.3390/ijns9020022
BibTeX
@article{King2023,
author = {King, Jovanka R and Grill, Kalle and Hammarström, Lennart},
title = {Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations},
journal = {International Journal of Neonatal Screening},
year = {2023},
volume = {9},
number = {2},
pages = {22},
doi = {10.3390/ijns9020022}
}
EUVIMED